The Ketogenic Diet in Children with Epilepsy: A Focus on Parental Stress and Family Compliance

Francesca Felicia Operto1, Angelo Labate2, Salvatore Aiello1

  • 1Child and Adolescent Neuropsychiatry Unit, Department of Medicine, Surgery, and Odontoiatry, University of Salerno, 84084 Salerno, Italy.

Nutrients
|February 25, 2023
PubMed

Insights

Parental stress significantly increased after 12 months on a ketogenic diet for drug-resistant epilepsy. Long-term adherence requires additional parental support and encouragement.

Area of Science:

  • Neurology
  • Pediatrics
  • Dietary Therapy

Background:

  • Drug-resistant epilepsy affects numerous children.
  • Ketogenic diet is a therapeutic option for seizure control.
  • Parental well-being is crucial for treatment adherence.

Purpose of the Study:

  • To assess parental stress levels during ketogenic diet therapy.
  • To identify changes in parental stress at 6 and 12 months.
  • To explore correlations between parental stress and clinical variables.

Main Methods:

  • 36 children (3-10 years) with drug-resistant epilepsy were enrolled.
  • Parental stress was measured using the Parenting Stress Index-PSI at baseline, 6, and 12 months.
  • Demographic and clinical data were collected and analyzed.

Main Results:

  • Parental stress scores (Parental Distress and Total Stress) significantly increased after 12 months.
  • Stress levels showed a significant rise between 6 and 12 months.
  • No significant relationships were found between parental stress and epilepsy type, duration, seizure frequency, medications, comorbidities, or diet efficacy/adverse events.

Conclusions:

  • The ketogenic diet can impose a significant long-term burden on parents.
  • Parents may experience feelings of inadequacy, impacting their role.
  • Enhanced parental support is vital for optimizing adherence and managing stress during ketogenic diet therapy.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
236
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
235
Overview of Metabolism01:40

Overview of Metabolism

Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
31.6K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
493
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
457
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
100